Immediate implant placement for posterior teeth using a sealing socket abutment.
Immediate Implant Placement in the Posterior Region Combining Sealing Socket Abutment and Peri-implant Socket Filling.A Randomized Controlled Clinical Trial
NA · University of Liege · NCT05741749
This study is testing if a new type of dental implant cover can help keep the shape of the gums and jawbone better after placing implants in the back teeth for patients who need molars removed.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | University of Liege (other) |
| Locations | 1 site (Liège) |
| Trial ID | NCT05741749 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of a sealing socket abutment (SSA) in preserving soft tissue contour and alveolar ridge profile after immediate dental implant placement in the posterior region. It compares the outcomes of using SSA versus a standard healing abutment, focusing on soft tissue changes, hard tissue remodeling, and overall esthetic results. Patients with hopeless maxillary or mandibular molars will be recruited, and various health parameters will be assessed to ensure eligibility. The study will also measure patient-related outcomes to gauge satisfaction with the procedure.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old in good general health with specific dental conditions allowing for immediate implant placement.
Not a fit: Patients with autoimmune diseases, uncontrolled diabetes, or those requiring specific medical treatments prior to the procedure may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved aesthetic outcomes and better preservation of the alveolar ridge after dental implant procedures.
How similar studies have performed: While similar approaches have been explored, this specific combination of techniques is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Good general health (ASA I/II), * More than 18 years old, * Smoker \< 10c/day, one hopeless tooth, * Healthy periodontal condition, * Presence of at least 2 mm of keratinized gingiva * Intact buccal bone wall * Adequate plaque control (FMPS ≤ 25%) * Adequate bone quantity allowing an immediate implant procedure (apical bone height of at - Least 5 mm or presence of interradicular septum) * Written consent provided Exclusion Criteria: * Auto-immune disease or immunocompromised patients * Uncontrolled diabetes * Use of steroids or biphosphonates * Local or systemic infection (medical treatment needed prior to entrance to the study) * Pregnancy or breastfeeding * Alcoholism or chronically drug abuse * Bone availability requiring an angulated abutment * Untreated local inflammation * Cyst * Mucosal disease or oral lesions * Local irradiation therapy * Oral communication with sinus after the extraction
Where this trial is running
Liège
- CHU de Liège — Liège, Belgium (RECRUITING)
Study contacts
- Study coordinator: Bruno De Carvalho, DDS, Ms, PhD Fellow
- Email: bruno.decarvalho@chuliege.be
- Phone: +32479510961
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Dental Implantation, Sealing Socket Abutment, Immediate implant, Peri implant tissue changes